Listeria monocytogenes personalized cancer vaccines drive therapeutic immune responses to cancer derived neoantigens
暂无分享,去创建一个
J. Johnston | J. DeVoss | J. Lesch | H. Phee | Olga Pryshchep | Nithya Thambi | Zhiyong Cheng | Daniel O. Villarreal | D. Balli | Petia Mitchell | S. Hayes | B. Coder | M. Princiotta | Xiaoming Ju | Kim Ramos | R. Petit | K. Cooke | Dipti Kelkar | Elena V. Filippova | Cristina Mottershead | B. Lugt | Xian Liu | Siyuan Liu | J. Zhan | N. Thambi | D. Kelkar | Elena V Filippova | Justin Lesch | O. Pryshchep | Brandon D. Coder
[1] T A Chan,et al. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] Gabriel N. Teku,et al. Pan-cancer analysis of neoepitopes , 2018, Scientific Reports.
[3] J. Flickinger,et al. Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress , 2018, Vaccines.
[4] K. Kabashima,et al. Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations , 2018, Front. Oncol..
[5] I. Melero,et al. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] A. Levine,et al. A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy , 2017, Nature.
[7] F. Kühnel,et al. CD4 and CD8 T lymphocyte interplay in controlling tumor growth , 2017, Cellular and Molecular Life Sciences.
[8] G. Linette,et al. Neoantigen Vaccines Pass the Immunogenicity Test. , 2017, Trends in molecular medicine.
[9] J. Utikal,et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer , 2017, Nature.
[10] Charles H. Yoon,et al. An immunogenic personal neoantigen vaccine for patients with melanoma , 2017, Nature.
[11] C. Zahnow,et al. Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. , 2017, Cancer discovery.
[12] N. McGranahan,et al. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.
[13] O. Ohara,et al. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole‐exome sequencing , 2017, Cancer science.
[14] J. Gartner,et al. T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer. , 2016, The New England journal of medicine.
[15] Özlem Türeci,et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy , 2016, Nature.
[16] Nicolai J. Birkbak,et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade , 2016, Science.
[17] I. Mellman,et al. Neo approaches to cancer vaccines , 2015, Science.
[18] E. Mardis,et al. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells , 2015, Science.
[19] J. Castle,et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer , 2015, Nature.
[20] V. Badovinac,et al. Listeria monocytogenes: a model pathogen to study antigen-specific memory CD8 T cell responses , 2015, Seminars in Immunopathology.
[21] T. Schumacher,et al. Neoantigens in cancer immunotherapy , 2015, Science.
[22] E. Wherry,et al. Overcoming T cell exhaustion in infection and cancer. , 2015, Trends in immunology.
[23] Z. Modrušan,et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing , 2014, Nature.
[24] J. Berzofsky,et al. Episomal Expression of Truncated Listeriolysin O in LmddA-LLO–E7 Vaccine Enhances Antitumor Efficacy by Preferentially Inducing Expansions of CD4+FoxP3− and CD8+ T Cells , 2014, Cancer Immunology Research.
[25] L. Wood,et al. Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy , 2014, Front. Cell. Infect. Microbiol..
[26] S. Rosenberg,et al. Exploiting the curative potential of adoptive T‐cell therapy for cancer , 2014, Immunological reviews.
[27] H. Schreiber,et al. Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.
[28] Pia Kvistborg,et al. The cancer antigenome , 2012, The EMBO journal.
[29] P. Maciag,et al. Listeria monocytogenes-Derived Listeriolysin O Has Pathogen-Associated Molecular Pattern-Like Properties Independent of Its Hemolytic Ability , 2012, Clinical and Vaccine Immunology.
[30] J. Castle,et al. Exploiting the mutanome for tumor vaccination. , 2012, Cancer research.
[31] A. Oxenius,et al. Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination , 2011, Proceedings of the National Academy of Sciences.
[32] E John Wherry,et al. T cell exhaustion , 2011 .
[33] T. Honjo,et al. Negative co-receptors and ligands , 2011 .
[34] P. Maciag,et al. Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human , 2011, Cancer Gene Therapy.
[35] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[36] I. M. Belyakov,et al. What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens? , 2009, The Journal of Immunology.
[37] P. Maciag,et al. Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy , 2008, Clinical and Vaccine Immunology.
[38] B. Kyewski,et al. Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism , 2008, Proceedings of the National Academy of Sciences.
[39] F. Pijpers,et al. Therapeutic cancer vaccines , 2005, Nature Reviews Drug Discovery.
[40] D. Holdstock. Past, present--and future? , 2005, Medicine, conflict, and survival.
[41] E. Shevach. Fatal attraction: tumors beckon regulatory T cells , 2004, Nature Medicine.
[42] F. Rodríguez,et al. Immunodominance in Virus-Induced CD8+ T-Cell Responses Is Dramatically Modified by DNA Immunization and Is Regulated by Gamma Interferon , 2002, Journal of Virology.
[43] W. Goebel,et al. A Novel Approach of Direct Ex Vivo Epitope Mapping Identifies Dominant and Subdominant CD4 and CD8 T Cell Epitopes from Listeria monocytogenes1 , 2001, The Journal of Immunology.
[44] Jian-Bo Yang,et al. Past, Present and the Future , 1998 .
[45] P. A. Peterson,et al. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. , 1995, Proceedings of the National Academy of Sciences of the United States of America.